GlaxoSmithKlineE Dividend
Dividend criteria checks 2/6
GlaxoSmithKlineE is a dividend paying company with a current yield of 2.38%.
Key information
2.4%
Dividend yield
-40%
Payout ratio
Industry average yield | 3.0% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | ج.م0.89 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, BIOC has been paying a dividend for less than 10 years.
Growing Dividend: BIOC's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
GlaxoSmithKlineE Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (BIOC) | 2.4% |
Market Bottom 25% (EG) | 2.2% |
Market Top 25% (EG) | 6.2% |
Industry Average (Pharmaceuticals) | 3.0% |
Analyst forecast in 3 Years (BIOC) | n/a |
Notable Dividend: BIOC's dividend (2.38%) is higher than the bottom 25% of dividend payers in the EG market (2.22%).
High Dividend: BIOC's dividend (2.38%) is low compared to the top 25% of dividend payers in the EG market (6.23%).
Earnings Payout to Shareholders
Earnings Coverage: BIOC is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (27.5%), BIOC's dividend payments are well covered by cash flows.